Long-term health effects in childhood cancer survivors
Official title: The Swiss Childhood Cancer Survivor Study - Follow-up (SCCSS-FollowUp)
Run by University of Bern · NCT04732273 · Data updated 2026-11-12
This study looks at the long-term health effects that childhood cancer survivors in Switzerland may face as they grow up to help improve their care and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | University of Bern Academic / other |
| Locations | 3 sites (Basel and 2 other locations) |
| Status | Recruiting |
| Started | June 20, 2022 |
| Main results expected | January 1, 2071 |
| Study ends | January 1, 2071 |
| Registry record updated | September 23, 2025 |
| Trial ID | NCT04732273 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who were diagnosed with cancer at age 0-20 years, have completed their treatment, and are currently residing in Switzerland.
✕Probably not a fit
Patients who are in a palliative or relapsed situation where no follow-up examinations are planned will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The SCCSS-FollowUp is a national, multicenter cohort study aimed at investigating the late effects experienced by childhood cancer survivors in Switzerland. This observational study collects data through clinical examinations, laboratory tests, functional assessments, and questionnaires to understand the prevalence and risk factors associated with these late effects. By standardizing follow-up care and assessing survivors longitudinally, the study seeks to minimize chronic diseases and improve the quality of life for this population. The findings will help inform healthcare strategies for managing the long-term health of childhood cancer survivors.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and management of late effects in childhood cancer survivors, enhancing their quality of life.
How similar studies have gone: Other studies have successfully investigated late effects in childhood cancer survivors, indicating that this approach is both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
This prospective cohort study is based on the Childhood Cancer Registry (ChCR), a national, population-based cancer registry that includes all children and adolescents in Switzerland who were diagnosed with cancer at age 0-20 years. It includes patients diagnosed with leukemia, lymphoma, central nervous system tumors, and malignant solid tumors or Langerhans cell histiocytosis. Inclusion Criteria: * Registered in the Childhood Cancer Registry (ChCR) or treated and followed-up in a Swiss pediatric oncology (SPOG) clinic, but not registered in the ChCR because of residency in neighboring countries * Diagnosed at age 0 - 20 years * Childhood cancer treatment completed * All age categories at time of inclusion in the study (children, adolescents, adults) * Written informed consent Exclusion criteria: * Childhood cancer survivors in a palliative or relapsed situation where no follow-up examinations are foreseen.
Where it's running
-
University Childen's Hospital Basel
Basel, Switzerland Recruiting -
University Children's Hospital Bern
Bern, Switzerland Recruiting -
University Hospital Geneva
Geneva, Switzerland Recruiting
Study contacts
- Principal investigator: Claudia E Kuehni, MD — Institute of Social and Preventive Medicine, University of Bern
- Study coordinator: Claudia E Kuehni, MD
- Email: claudia.kuehni@unibe.ch
- Phone: +41 31 631 35 07
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Identifying genetic risks for complications in childhood cancer patients in Switzerland
This study is trying to find out if certain genetic differences can help explain the complications that childhood cancer patients in Switzerland might face after their treatment.
-
Community-led, family-centered communication for Hispanic childhood cancer survivors
This study tests a family-focused communication approach to help young Hispanic adult survivors, their families, and clinicians talk more effectively about survivorship care.
-
Blood biomarkers for treatment-related brain injury in children with brain tumors
This project will test whether blood plasma biomarkers can show treatment-related brain injury in children with primary brain tumors by comparing those who receive radiotherapy, those who do not, and healthy children of the same age and sex.
-
At-home light therapy for chemo-related nerve pain in childhood cancer survivors
This study tests whether a six-week at-home light therapy program can help childhood cancer survivors who have chemotherapy-induced peripheral neuropathy.
-
Understanding the needs of siblings of children with cancer
This study looks at the emotional struggles of siblings of kids with cancer to see how they feel and what support they need during this tough time.
-
Cognitively engaging exercise to boost thinking skills in children and teens with cancer
This trial tests whether mentally challenging physical activity can improve thinking skills and self-control (executive functions) in children and adolescents undergoing cancer treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.